We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

BioPerfectus Technologies

Bioperfectus Technologies Co., Ltd. is one of the leading molecular diagnostic solution providers in the global in-vi... read more Featured Products: More products

Download Mobile App





Bioperfectus Showcases Its Molecular Diagnostic Products for Infectious Diseases at MEDLAB 2022 Online

By LabMedica International staff writers
Posted on 25 Jan 2022
Print article
Image: STC-96A Real-Time PCR System (Photo courtesy of Bioperfectus)
Image: STC-96A Real-Time PCR System (Photo courtesy of Bioperfectus)

Jiangsu Bioperfectus Technologies Co., Ltd. (Shanghai, China) presented its molecular diagnostic products for various infectious diseases at MEDLAB 2022 Online from January 5 to February 28, 2022.

Bioperfectus used its virtual booth to exhibit the STC-96A Real-Time PCR system and STC-96A Plus Real-Time PCR system that are more-than-ever flexible, efficient and reliable breakthrough in the real-time PCR analysis of gene expression and genetic variation. The temperature uniformity of the STC-96A Plus and STC-96A Plus across 96 wells is within a remarkable 0.1℃, which meets all needs for highly precise diagnostic and study use, including High-Resolution Melting Curve (HRM) applications

Bioperfectus also highlighted its COVID-19 testing solutions, including the COVID-19 Coronavirus Real Time PCR Kit, an In Vitro Diagnostic (IVD) reagent using fluorescent PCR technology to qualitatively detect Open Reading Frame gene region (ORF1a/b) and viral nucleocapsid region (N) of SARS-CoV-2 RNA from upper and lower respiratory tract specimens. In addition, the company presented the Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit, including Prepacked Extraction Tube, which is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in nasopharyngeal swabs from individuals who are suspected of COVID-19 within the first seven days of the onset of symptoms.

Visitors exploring its online booth also viewed the Nucleic Acid Extraction Solutions produced by Bioperfectus that offer a comprehensive PCR laboratory solution, including SSNP series Nucleic Acid Extraction System (3000A, 2000B & 9600A), Nucleic Acid Extraction Rapid Kit (Magnetic Bead Method) as well as Viral Nucleic Acid Isolation Kit (Silica-Based Spin Column), which integrates new technologies such as machine, electricity and computer software to enable automatic nucleic acid extraction in one time.

Related Links:
Jiangsu Bioperfectus Technologies Co., Ltd.

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Automatic ELISA Workstation
URANUS AE65

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: The HelioLiver Dx test has met the coprimary and secondary study endpoints in the CLiMB trial (Photo courtesy of Helio Genomics)

Blood-Based Test Outperforms Ultrasound in Early Liver Cancer Detection

Patients with liver cirrhosis and chronic hepatitis B are at a higher risk for developing hepatocellular carcinoma (HCC), the most prevalent type of liver cancer. The American Association for the Study... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Microbiology

view channel
Image: The POC PCR test shortens time for STI test results (Photo courtesy of Visby Medical)

POC STI Test Shortens Time from ED Arrival to Test Results

In a 2024 sexually transmitted infections (STIs) surveillance report by the World Health Organization (WHO), over 2.5 million cases were recorded, alongside a rise in the inappropriate use of antibiotics... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.